↓ Skip to main content

Dove Medical Press

Riluzole: real-world evidence supports significant extension of median survival times in patients with amyotrophic lateral sclerosis

Overview of attention for article published in Degenerative Neurological and Neuromuscular Disease, May 2017
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (92nd percentile)

Mentioned by

news
3 news outlets
twitter
1 X user
facebook
1 Facebook page

Citations

dimensions_citation
70 Dimensions

Readers on

mendeley
154 Mendeley
Title
Riluzole: real-world evidence supports significant extension of median survival times in patients with amyotrophic lateral sclerosis
Published in
Degenerative Neurological and Neuromuscular Disease, May 2017
DOI 10.2147/dnnd.s135748
Pubmed ID
Authors

Michael Hinchcliffe, Alan Smith

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 154 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 154 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 21 14%
Student > Ph. D. Student 20 13%
Student > Master 17 11%
Researcher 15 10%
Student > Doctoral Student 7 5%
Other 15 10%
Unknown 59 38%
Readers by discipline Count As %
Neuroscience 25 16%
Medicine and Dentistry 20 13%
Biochemistry, Genetics and Molecular Biology 19 12%
Pharmacology, Toxicology and Pharmaceutical Science 9 6%
Agricultural and Biological Sciences 7 5%
Other 15 10%
Unknown 59 38%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 31. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 04 April 2024.
All research outputs
#1,282,306
of 25,639,676 outputs
Outputs from Degenerative Neurological and Neuromuscular Disease
#6
of 95 outputs
Outputs of similar age
#24,782
of 325,274 outputs
Outputs of similar age from Degenerative Neurological and Neuromuscular Disease
#2
of 3 outputs
Altmetric has tracked 25,639,676 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 94th percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 95 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 9.8. This one has done particularly well, scoring higher than 93% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 325,274 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 92% of its contemporaries.
We're also able to compare this research output to 3 others from the same source and published within six weeks on either side of this one.